世界の軽・中度アトピー性皮膚炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3791
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、軽・中度アトピー性皮膚炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（放射線治療、薬物治療）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・軽・中度アトピー性皮膚炎治療の市場動向
・企業の競争状況、市場シェア
・軽・中度アトピー性皮膚炎治療の種類別市場規模（放射線治療、薬物治療）
・軽・中度アトピー性皮膚炎治療の用途別市場規模（病院薬局、小売薬局、オンライン薬局）
・軽・中度アトピー性皮膚炎治療の北米市場規模2016-2027（アメリカ、カナダ）
・軽・中度アトピー性皮膚炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・軽・中度アトピー性皮膚炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・軽・中度アトピー性皮膚炎治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・軽・中度アトピー性皮膚炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis、Pfizer、Sanofi、Anacor Pharmaceuticals、Astellas Pharma、Meda Pharmaceuticals、Regeneron Pharmaceuticals、Bausch Health）
・結論

Mild-to-moderate atopic dermatitis is a chronic inflammatory skin disease often confined to the flexural surfaces of the body and usually begins in childhood.
Drug treatment can further be segmented into antihistamines, antibiotics, emollients, corticosteroids, and calcineurin inhibitors.

Market Analysis and Insights: Global Mild-to-Moderate Atopic Dermatitis Treatment Market
The global Mild-to-Moderate Atopic Dermatitis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mild-to-Moderate Atopic Dermatitis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mild-to-Moderate Atopic Dermatitis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mild-to-Moderate Atopic Dermatitis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mild-to-Moderate Atopic Dermatitis Treatment market.

Global Mild-to-Moderate Atopic Dermatitis Treatment Scope and Market Size
Mild-to-Moderate Atopic Dermatitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mild-to-Moderate Atopic Dermatitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Radiation Treatment
Drug Treatment

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Pfizer
Sanofi
Anacor Pharmaceuticals
Astellas Pharma
Meda Pharmaceuticals
Regeneron Pharmaceuticals
Bausch Health

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Radiation Treatment
1.2.3 Drug Treatment
1.3 Market by Application
1.3.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Perspective (2016-2027)
2.2 Mild-to-Moderate Atopic Dermatitis Treatment Growth Trends by Regions
2.2.1 Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mild-to-Moderate Atopic Dermatitis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Mild-to-Moderate Atopic Dermatitis Treatment Industry Dynamic
2.3.1 Mild-to-Moderate Atopic Dermatitis Treatment Market Trends
2.3.2 Mild-to-Moderate Atopic Dermatitis Treatment Market Drivers
2.3.3 Mild-to-Moderate Atopic Dermatitis Treatment Market Challenges
2.3.4 Mild-to-Moderate Atopic Dermatitis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Mild-to-Moderate Atopic Dermatitis Treatment Players by Revenue
3.1.1 Global Top Mild-to-Moderate Atopic Dermatitis Treatment Players by Revenue (2016-2021)
3.1.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mild-to-Moderate Atopic Dermatitis Treatment Revenue
3.4 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Concentration Ratio
3.4.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mild-to-Moderate Atopic Dermatitis Treatment Revenue in 2020
3.5 Mild-to-Moderate Atopic Dermatitis Treatment Key Players Head office and Area Served
3.6 Key Players Mild-to-Moderate Atopic Dermatitis Treatment Product Solution and Service
3.7 Date of Enter into Mild-to-Moderate Atopic Dermatitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Mild-to-Moderate Atopic Dermatitis Treatment Breakdown Data by Type
4.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Type (2022-2027)

5 Mild-to-Moderate Atopic Dermatitis Treatment Breakdown Data by Application
5.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2016-2027)
6.2 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
6.2.1 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2021)
6.2.2 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2022-2027)
6.2.3 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2027)
6.3 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application
6.3.1 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2021)
6.3.2 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2022-2027)
6.3.3 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2027)
6.4 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country
6.4.1 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2016-2021)
6.4.2 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2016-2027)
7.2 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
7.2.1 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2027)
7.3 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application
7.3.1 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2027)
7.4 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country
7.4.1 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
8.2.1 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application
8.3.1 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region
8.4.1 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2016-2027)
9.2 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
9.2.1 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2027)
9.3 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application
9.3.1 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2027)
9.4 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country
9.4.1 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
10.2.1 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application
10.3.1 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country
10.4.1 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.1.4 Novartis Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.2.4 Pfizer Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.3.4 Sanofi Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Anacor Pharmaceuticals
11.4.1 Anacor Pharmaceuticals Company Details
11.4.2 Anacor Pharmaceuticals Business Overview
11.4.3 Anacor Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.4.4 Anacor Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
11.4.5 Anacor Pharmaceuticals Recent Development
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Details
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.5.4 Astellas Pharma Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
11.5.5 Astellas Pharma Recent Development
11.6 Meda Pharmaceuticals
11.6.1 Meda Pharmaceuticals Company Details
11.6.2 Meda Pharmaceuticals Business Overview
11.6.3 Meda Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.6.4 Meda Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
11.6.5 Meda Pharmaceuticals Recent Development
11.7 Regeneron Pharmaceuticals
11.7.1 Regeneron Pharmaceuticals Company Details
11.7.2 Regeneron Pharmaceuticals Business Overview
11.7.3 Regeneron Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.7.4 Regeneron Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
11.7.5 Regeneron Pharmaceuticals Recent Development
11.8 Bausch Health
11.8.1 Bausch Health Company Details
11.8.2 Bausch Health Business Overview
11.8.3 Bausch Health Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.8.4 Bausch Health Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
11.8.5 Bausch Health Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Radiation Treatment
Table 3. Key Players of Drug Treatment
Table 4. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Regions (2016-2021)
Table 8. Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Regions (2022-2027)
Table 10. Mild-to-Moderate Atopic Dermatitis Treatment Market Trends
Table 11. Mild-to-Moderate Atopic Dermatitis Treatment Market Drivers
Table 12. Mild-to-Moderate Atopic Dermatitis Treatment Market Challenges
Table 13. Mild-to-Moderate Atopic Dermatitis Treatment Market Restraints
Table 14. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Players (2016-2021)
Table 16. Global Top Mild-to-Moderate Atopic Dermatitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mild-to-Moderate Atopic Dermatitis Treatment as of 2020)
Table 17. Ranking of Global Top Mild-to-Moderate Atopic Dermatitis Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Mild-to-Moderate Atopic Dermatitis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Mild-to-Moderate Atopic Dermatitis Treatment Product Solution and Service
Table 21. Date of Enter into Mild-to-Moderate Atopic Dermatitis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 64. Novartis Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 69. Pfizer Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 74. Sanofi Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Anacor Pharmaceuticals Company Details
Table 77. Anacor Pharmaceuticals Business Overview
Table 78. Anacor Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 79. Anacor Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021) & (US$ Million)
Table 80. Anacor Pharmaceuticals Recent Development
Table 81. Astellas Pharma Company Details
Table 82. Astellas Pharma Business Overview
Table 83. Astellas Pharma Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 84. Astellas Pharma Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021) & (US$ Million)
Table 85. Astellas Pharma Recent Development
Table 86. Meda Pharmaceuticals Company Details
Table 87. Meda Pharmaceuticals Business Overview
Table 88. Meda Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 89. Meda Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021) & (US$ Million)
Table 90. Meda Pharmaceuticals Recent Development
Table 91. Regeneron Pharmaceuticals Company Details
Table 92. Regeneron Pharmaceuticals Business Overview
Table 93. Regeneron Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 94. Regeneron Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021) & (US$ Million)
Table 95. Regeneron Pharmaceuticals Recent Development
Table 96. Bausch Health Company Details
Table 97. Bausch Health Business Overview
Table 98. Bausch Health Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021) & (US$ Million)
Table 99. Bausch Health Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Radiation Treatment Features
Figure 3. Drug Treatment Features
Figure 4. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Mild-to-Moderate Atopic Dermatitis Treatment Report Years Considered
Figure 9. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Regions (2022-2027)
Figure 13. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Players in 2020
Figure 14. Global Top Mild-to-Moderate Atopic Dermatitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mild-to-Moderate Atopic Dermatitis Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Mild-to-Moderate Atopic Dermatitis Treatment Revenue in 2020
Figure 16. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2016-2027)
Figure 20. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2016-2027)
Figure 21. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Country (2016-2027)
Figure 22. United States Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2016-2027)
Figure 26. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2016-2027)
Figure 27. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Country (2016-2027)
Figure 28. Germany Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Region (2016-2027)
Figure 38. China Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
Figure 60. Anacor Pharmaceuticals Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
Figure 61. Astellas Pharma Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
Figure 62. Meda Pharmaceuticals Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
Figure 63. Regeneron Pharmaceuticals Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
Figure 64. Bausch Health Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界のアトピー性皮膚炎治療市場規模・現状・予測（2021年-2027年）

Global Atopic Dermatitis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0495 2021年4月 95Pages
QYResearch社発行の本調査資料では、アトピー性皮膚炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所、経口、注射可能）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア、通信販売薬局、皮膚科クリニック）、主要地...

世界のアトピー性皮膚炎治療市場規模・現状・予測（2021年-2027年）

世界の犬アトピー性皮膚炎治療市場規模・現状・予測（2021年-2027年）

Global Canine Atopic Dermatitis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1081 2021年4月 93Pages
QYResearch社発行の本調査資料では、犬アトピー性皮膚炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、局所、注射可能）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界の犬アトピー性皮膚炎治療市場 2021：企業別、地域別、種類・用途別

Global Canine Atopic Dermatitis Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z02687 2021年4月 103Pages
当調査資料では、犬アトピー性皮膚炎治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。犬アトピー性皮膚炎治療の種類別市場規模（経口、局所、注射可能）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本...

世界の脂漏性皮膚炎治療市場規模・現状・予測（2021年-2027年）

Global Seborrheic Dermatitis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5150 2021年4月 97Pages
QYResearch社発行の本調査資料では、脂漏性皮膚炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、局所）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界のアトピー性湿疹治療市場規模・現状・予測（2021年-2027年）

Global Atopic Eczema Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0496 2021年4月 96Pages
QYResearch社発行の本調査資料では、アトピー性湿疹治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、局所、非経口）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の放射線皮膚炎治療市場規模・現状・予測（2021年-2027年）

Global Radiation Dermatitis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4895 2021年4月 92Pages
QYResearch社発行の本調査資料では、放射線皮膚炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、局所、包帯）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界のアレルギー性接触皮膚炎（ACDS）市場規模・現状・予測（2021年-2027年）

Global Allergic Contact Dermatitis (ACDS) Market Size, Status and Forecast 2021-2027
QYR2104Z0241 2021年4月 98Pages
QYResearch社発行の本調査資料では、アレルギー性接触皮膚炎（ACDS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（糖質コルチコイド、局所ステロイド、その他外用剤、コルチコステロイド、抗コリン作用性制吐剤、その他抗不安薬、鎮静剤・催眠...

世界のアトピー性湿疹治療市場 2021：企業別、地域別、種類・用途別

Global Atopic Eczema Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z01188 2021年4月 108Pages
当調査資料では、アトピー性湿疹治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アトピー性湿疹治療の種類別市場規模（経口、局所、非経口）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、...

世界の軽度認知障害治療市場規模・現状・予測（2021年-2027年）

Global Mild Cognitive Impairment Therapeutic Market Size, Status and Forecast 2021-2027
QYR2104Z3790 2021年4月 131Pages
QYResearch社発行の本調査資料では、軽度認知障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（BAN-2401、ボスチニブ、ブレキサノロン、CSP-1103、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模...

世界のアトピー性皮膚炎治療市場規模・現状・予測（2021年-2027年） Atopic dermatitis is a chronic disease that causes inflammation of the skin and results in red, itchy, swollen, and cracked skin. Market Analysis and Insights: Global Atopic Dermatitis Treatment Market The global Atopic Dermatitis Treatment market size is projected to reach US$ XX million by 2026, f…
世界のアトピー性皮膚炎治療市場規模・現状・予測（2021年-2027年） Atopic dermatitis is a chronic disease that causes inflammation of the skin and results in red, itchy, swollen, and cracked skin. Market Analysis and Insights: Global Atopic Dermatitis Treatment Market The global Atopic Dermatitis Treatment market size is projected to reach US$ XX million by 2026, f…
世界の犬アトピー性皮膚炎治療市場規模・現状・予測（2021年-2027年） Canine atopic dermatitis is a problem that is related to the skin, which when exposed to the allergens results in allergic symptoms. Market Analysis and Insights: Global Canine Atopic Dermatitis Treatment Market The global Canine Atopic Dermatitis Treatment market size is projected to reach US$ XX m…
世界の放射線皮膚炎治療市場規模・現状・予測（2021年-2027年） The pathophysiology of a radiation skin reaction is a combination of radiation injury and the subsequent inflammatory response and can occur at both the entrance and exit site of the irradiation. The major factor driving the radiation dermatitis treatment market is the increasing prevalence of cance…
世界の犬アトピー性皮膚炎治療市場 2021：企業別、地域別、種類・用途別 The Canine Atopic Dermatitis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…